At Materialize Bio, we're pushing the boundaries of MedTech by developing advanced biopolymer-based implants. We believe in creating solutions that are safer, more natural, and better for the body than traditional metal and plastic. Materialize Bio is a Tufts-spin out with disruptive and highly scalable 3D manufacturing methods tailored specifically for biopolymers. Materialize's platform taps into the exceptional regenerative, antimicrobial and material properties of natural biopolymers, which are wildly underutilized as medical implants because of difficulties in fast, cost-effective prototyping and efficient production. With a range of concepts, their first focus is bringing breakthrough biopolymer ear tubes to market, with novel features and drug-elution capabilities. They are uniquely positioned to enhance the quality of healthcare with their functionalized implants, marking a pivotal moment as biopolymer technology finally makes its dent in both high-volume and personalized implant markets.
| Website | https://www.materializebio.com |
| Employees | 3 (2 on RocketReach) |
| Founded | 2023 |
| Industry | Biotechnology Research |
| Keywords | Medical Implants, Biomedical Engineering, Biocompatible Materials, Polymer Science, Advanced Biomaterials, Biopolymer Technology, Drug Delivery Systems, Regenerative Medicine, Minimally Invasive Surgery, Tissue Engineering, Medical Technology, Surgical Implants, Orthopedic Implants, Medical Devices, Dental Implants, Plastic Surgery |
Looking for a particular Materialize Bio employee's phone or email?
Joanna Xylas is the Cofounder and CEO of Materialize Bio.
2 people are employed at Materialize Bio.